Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs Julia KirchheinerIvar RootsJürgen Brockmöller Review Article 30 September 2012 Pages: 1209 - 1225
Comparative Pharmacokinetics of Vitamin K Antagonists Mike Ufer Review Article 30 September 2012 Pages: 1227 - 1246
Clinical Pharmacology of Lumiracoxib Christiane M. RordorfLes ChoiJames B. Mangold Review Article 30 September 2012 Pages: 1247 - 1266
High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy Cécile GoujardMayeule LegrandAnne-Marie Taburet Original Research Article 30 September 2012 Pages: 1267 - 1278
Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy Volunteers Mona DarwishKenneth TemperoJeffrey Thompson Original Research Article 30 September 2012 Pages: 1279 - 1286
Penetration of Orally Administered Prulifloxacin Into Human Lung Tissue Ercole ConciaBenedetta AllegranziPaolo Dionisio Original Research Article 30 September 2012 Pages: 1287 - 1294
Population Pharmacokinetics of Onercept in Healthy Subjects Sophie GlattEliane FuseauQuyen T. X. Nguyen Original Research Article 30 September 2012 Pages: 1295 - 1304
Cystatin C as a New Covariate to Predict Renal Elimination of Drugs Fabienne ThomasSophie Séronie-VivienEtienne Chatelut Original Research Article 30 September 2012 Pages: 1305 - 1316
Pharmacokinetic Study of Tacrolimus in Cystic Fibrosis and Non-Cystic Fibrosis Lung Transplant Patients and Design of Bayesian Estimators Using Limited Sampling Strategies Franck Saint-MarcouxChristiane KnoopPierre Marquet Original Research Article 30 September 2012 Pages: 1317 - 1328
Population Pharmacokinetics of Olmesartan Following Oral Administration of its Prodrug, Olmesartan Medoxomil Kazutaka YoshiharaYuying GaoMasafumi Hisaoka Original Research Article 30 September 2012 Pages: 1329 - 1342
